Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX)

Q: What does CUSIP 20454B104 represent in this 13F holders report?

CUSIP 20454B104 is the security identifier for CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q2 2023?

72 institutional investors reported CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 20454B104

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 180,577,721
Total 13F shares: 90,478,972
Share change: +8,915,303
Total reported value: $287,651,504
Price per share: $3.18
Number of holders: 72
Value change: +$28,216,829
Number of buys: 43
Number of sells: 43

Quarterly Holders Quick Answers

What is CUSIP 20454B104?
CUSIP 20454B104 identifies CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 20454B104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	12%	22,362,850	$73,126,520	—	31 Mar 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	3.5%	6,250,000	$20,437,500	—	31 Mar 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.3%	6,004,473	$19,616,292	—	31 Mar 2023	13F
FMR LLC	13F	Company	3.1%	5,681,072	$18,577,106	—	31 Mar 2023	13F
Rock Springs Capital Management LP	13F	Company	3.1%	5,513,788	$18,030,087	—	31 Mar 2023	13F
Blackstone Inc.	13F	Company	2.6%	4,620,998	$15,110,663	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	2%	3,689,326	$12,064,095	—	31 Mar 2023	13F
Vivo Capital, LLC	13F	Company	2%	3,556,023	$11,628,195	—	31 Mar 2023	13F
Foresite Capital Management V, LLC	13F	Company	1.9%	3,480,723	$11,381,964	—	31 Mar 2023	13F
BRAIDWELL LP	13F	Company	1.8%	3,247,847	$10,620,460	—	31 Mar 2023	13F
CHI Advisors LLC	13F	Company	1.6%	2,829,712	$9,253,158	—	31 Mar 2023	13F
Monashee Investment Management LLC	13F	Company	1.2%	2,177,042	$7,118,927	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	1%	1,825,000	$5,967,750	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	0.86%	1,557,630	$5,093,450	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.85%	1,540,895	$5,038,726	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.54%	978,403	$3,199,000	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.49%	883,563	$2,889,251	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.43%	782,617	$2,559,158	—	31 Mar 2023	13F
Prosight Management, LP	13F	Company	0.38%	678,300	$2,218,041	—	31 Mar 2023	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.22%	403,062	$1,318,013	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.22%	402,313	$1,315,564	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.21%	382,385	$1,250,399	—	31 Mar 2023	13F
CAXTON CORP	13F	Company	0.12%	211,740	$675,451	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	198,522	$649,167	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.1%	185,303	$605,941	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.09%	163,400	$534,318	—	31 Mar 2023	13F
Qube Research & Technologies Ltd	13F	Company	0.09%	162,624	$531,780	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.09%	160,064	$523,409	—	31 Mar 2023	13F
LMR Partners LLP	13F	Company	0.08%	146,173	$477,986	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.08%	142,941	$467,417	—	31 Mar 2023	13F
DAFNA Capital Management LLC	13F	Company	0.06%	116,882	$382,204	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.05%	93,980	$307,314	—	31 Mar 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.04%	69,856	$223,539	—	31 Mar 2023	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.04%	66,392	$217,102	—	31 Mar 2023	13F
MARSHALL WACE, LLP	13F	Company	0.04%	65,177	$213,129	—	31 Mar 2023	13F
CREDIT SUISSE AG/	13F	Company	0.03%	58,159	$190,180	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.03%	52,300	$171,000	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.03%	51,576	$168,654	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.02%	44,460	$145,384	—	31 Mar 2023	13F
WEDBUSH SECURITIES INC	13F	Company	0.02%	43,444	$142,000	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	42,767	$139,848	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.02%	40,986	$134,024	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.02%	39,306	$128,531	—	31 Mar 2023	13F
683 Capital Management, LLC	13F	Company	0.02%	38,039	$124,388	—	31 Mar 2023	13F
SALEM INVESTMENT COUNSELORS INC	13F	Company	0.02%	30,000	$98,100	—	31 Mar 2023	13F
Jump Financial, LLC	13F	Company	0.02%	27,310	$89,304	—	31 Mar 2023	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.01%	26,945	$88,110	—	31 Mar 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.01%	26,828	$87,728	—	31 Mar 2023	13F
Diametric Capital, LP	13F	Company	0.01%	26,227	$85,762	—	31 Mar 2023	13F
New Capital Management LP	13F	Company	0.01%	24,243	$79,275	—	31 Mar 2023	13F

Institutional Holders of Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) as of Q2 2023

As of 30 Jun 2023, Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 90,478,972 shares. The largest 10 holders included ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, BlackRock Inc., Blackstone Inc., BRAIDWELL LP, FMR LLC, Rock Springs Capital Management LP, VANGUARD GROUP INC, and Vivo Capital, LLC. This page lists 72 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.